Breakthrough Candida albicans bloodstream infection associated with in vivo development of pan-azole resistance related to ERG3 gene deletion

Pathology. 2024 Jun;56(4):578-579. doi: 10.1016/j.pathol.2023.09.015. Epub 2023 Nov 25.

¹ Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Westmead Hospital, Westmead, NSW, Australia; Sydney ID, The University of Sydney, Sydney, NSW, Australia; Medical School, The University of Wollongong, Wollongong, NSW, Australia; Southern IML Pathology, Sonic Healthcare, Wollongong, NSW, Australia. Electronic address: caitlin.keighley@sydney.edu.au.
² Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Westmead Hospital, Westmead, NSW, Australia; Sydney ID, The University of Sydney, Sydney, NSW, Australia.
³ Medical School, The University of Wollongong, Wollongong, NSW, Australia; Microbiology, NSW Health Pathology, Wollongong Hospital, Wollongong, NSW, Australia; Australian Red Cross Lifeblood, Brisbane, Qld, Australia.
⁴ Medical School, The University of Wollongong, Wollongong, NSW, Australia; Microbiology, NSW Health Pathology, Wollongong Hospital, Wollongong, NSW, Australia.

No abstract available

Publication types